Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
暂无分享,去创建一个
V. Wong | V. de Lédinghen | M. Stepanova | Y. Eguchi | A. Duseja | Z. Younossi | M. Romero-Gómez | J. George | E. Bugianesi | Aijaz Ahmed | R. Wong | Y. Yılmaz | M. Arrese | I. Jacobson | N. Méndez-Sánchez | L. Serfaty | M. El kassas | J. Ong | G. Papatheodoridis | F. Nader | M. Castellanos-Fernández | A. Afendy | I. Younossi | M. Ziayee | M. Romero‐Gomez | Yuichiro Eguchi
[1] V. Wong,et al. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] K. Hajifathalian,et al. Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study , 2017, Hepatology.
[3] B. Neuschwander‐Tetri,et al. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[4] Michael Charlton,et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.
[5] Rohit Loomba,et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease , 2017, Hepatology.
[6] Z. Younossi,et al. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities , 2017, Medicine.
[7] Robert Blissett,et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe , 2016, Hepatology.
[8] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[9] L. Henry,et al. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality. , 2016, Gastroenterology.
[10] Z. Younossi,et al. Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL) , 2016, Health and Quality of Life Outcomes.
[11] L. Henry,et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 , 2015, Hepatology.
[12] Kazuhide Yamamoto,et al. Roles of alcohol consumption in fatty liver: a longitudinal study. , 2015, Journal of hepatology.
[13] Aijaz Ahmed,et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.
[14] H. Conjeevaram,et al. Effect of lifetime alcohol consumption on the histological severity of non‐alcoholic fatty liver disease , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[15] A. Sanyal,et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). , 2012, Journal of hepatology.
[16] M. Stepanova,et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[17] E. Barrett-Connor,et al. Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study , 2009, Alimentary pharmacology & therapeutics.
[18] Per Christoffersen,et al. Final results of a long-term, clinical follow-up in fatty liver patients , 2009, Scandinavian journal of gastroenterology.
[19] J. Trinchet,et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features , 2007, Alimentary pharmacology & therapeutics.
[20] J. Montaner,et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.
[21] Z. Younossi,et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[22] P. Gartside,et al. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. , 1991, The American journal of gastroenterology.